地夫可特导致的不良反应怎么治疗？

Introduction: Deflazacort has been approved by the FDA to treat a specific type of muscular dystrophy - Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy is a severe childhood muscular dystrophy that primarily affects boys, with symptoms typically starting in early childhood, once they start walking. Deflazacort is the only corticosteroid officially approved for the treatment of DMD. But this does not mean that deflazacort is the only corticosteroid that can be used in practice to treat DMD. Prednisone is also frequently used to treat DMD.

Adverse reactions

1. Gastrointestinal diseases: indigestion, heartburn, nausea,

2. Infections: impetigo, upper respiratory tract infection, infection, sore throat, tooth abscess, urinary tract infection.

3. Musculoskeletal and connective tissue diseases: back pain, muscle spasm, myalgia, neck mass, neck pain, and limb pain.

4. Nervous system diseases: dizziness, psychomotor hyperactivity.

5. Mental illness: emotional instability, aggression, depression, mood disorders, moderate insomnia, mood changes, mood swings, and sleep disorders.

6. Kidney and urinary system diseases: abnormal urine color, painful urination, and hypertonia of the bladder.

7. Skin and subcutaneous tissue diseases: acne, alopecia, dermatitis.

Measures for dealing with adverse reactions of deflazacort

1. Weight gain and appetite: Patients should adjust their diet and lifestyle habits under the guidance of a doctor to control their weight.

2. Upper respiratory tract infection: Because deflazacort has an immunosuppressive effect, patients may be more susceptible to infection. Patients should maintain good personal hygiene and seek medical attention promptly if symptoms of infection occur.

3. Skin problems: such as local skin irritation, rash and itching. If skin problems occur, patients should seek medical attention immediately, and their doctor may adjust the dosage or provide other treatments.

4. Digestive system problems: such as gastrointestinal discomfort, nausea, vomiting, and loss of appetite. Patients should take deflazacort before and after eating, and follow the doctor's recommendations on diet and medication.

5. Immunosuppression: Long-term use of deflazacort may increase the risk of infection. Patients and family members should understand the possible infection risks caused by this drug and seek medical treatment promptly when symptoms of infection appear.

During the period of using deflazacort, patients and family members should maintain close communication with their doctors and conduct regular follow-up visits to ensure the effectiveness and safety of the treatment. If you have any discomfort or concerns, you should seek prompt medical advice.